Kindly MD (KDLY) Competitors $11.77 -0.32 (-2.65%) As of 07/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KDLY vs. VMD, TOI, DCGO, XGN, EUDA, SERA, QIPT, NAKA, ATPC, and CORBFShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Viemed Healthcare (VMD), Oncology Institute (TOI), DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), KindlyMD (NAKA), Agape ATP (ATPC), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry. Kindly MD vs. Its Competitors Viemed Healthcare Oncology Institute DocGo Exagen EUDA Health Sera Prognostics Quipt Home Medical KindlyMD Agape ATP Global Cord Blood Viemed Healthcare (NASDAQ:VMD) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation. Do institutionals & insiders have more ownership in VMD or KDLY? 74.2% of Viemed Healthcare shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by company insiders. Comparatively, 50.5% of Kindly MD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger earnings & valuation, VMD or KDLY? Viemed Healthcare has higher revenue and earnings than Kindly MD. Kindly MD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViemed Healthcare$224.26M1.18$11.27M$0.3022.30Kindly MD$2.47M28.69-$4.64M-$0.77-15.29 Is VMD or KDLY more profitable? Viemed Healthcare has a net margin of 5.28% compared to Kindly MD's net margin of 0.00%. Viemed Healthcare's return on equity of 9.49% beat Kindly MD's return on equity.Company Net Margins Return on Equity Return on Assets Viemed Healthcare5.28% 9.49% 7.14% Kindly MD N/A N/A N/A Does the media favor VMD or KDLY? In the previous week, Viemed Healthcare had 1 more articles in the media than Kindly MD. MarketBeat recorded 1 mentions for Viemed Healthcare and 0 mentions for Kindly MD. Viemed Healthcare's average media sentiment score of 0.93 beat Kindly MD's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Overall Sentiment Viemed Healthcare Positive Kindly MD Neutral SummaryViemed Healthcare beats Kindly MD on 10 of the 12 factors compared between the two stocks. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KDLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLY vs. The Competition Export to ExcelMetricKindly MDHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$70.88M$72.18M$5.57B$9.31BDividend YieldN/AN/A4.23%4.03%P/E Ratio-15.29N/A28.6119.73Price / Sales28.6910.35411.31174.27Price / CashN/A4.0236.0257.96Price / BookN/A1.158.235.67Net Income-$4.64M-$30.80M$3.23B$257.79M7 Day Performance-8.83%-4.42%-0.01%0.52%1 Month Performance-14.71%-7.36%5.60%8.84%1 Year Performance396.62%396.62%26.54%14.18% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KDLYKindly MDN/A$11.77-2.6%N/A+414.5%$70.88M$2.47M-15.29N/AVMDViemed Healthcare1.2371 of 5 stars$6.87-3.9%N/A-3.1%$282.60M$224.26M22.901,179TOIOncology Institute1.8538 of 5 stars$2.56+1.6%$7.00+173.4%+494.0%$224.87M$403.15M-3.66660Analyst ForecastGap UpDCGODocGo2.1823 of 5 stars$1.52-3.8%$3.56+134.2%-55.3%$161.13M$520.50M-76.004,407Positive NewsXGNExagen3.3316 of 5 stars$6.96-1.3%$7.50+7.8%+242.4%$150.16M$55.64M-8.29220News CoveragePositive NewsEUDAEUDA Health1.2549 of 5 stars$3.33-1.5%N/A-15.4%$125.59M$4.01M0.002Positive NewsSERASera Prognostics0.3976 of 5 stars$2.42-2.8%N/A-61.6%$93.81M$80K-2.57120Gap DownQIPTQuipt Home Medical2.9558 of 5 stars$1.73-2.8%$2.85+64.7%-35.3%$77.33M$245.91M-8.241,200NAKAKindlyMDN/A$12.04-5.6%N/AN/A$76.88M$2.47M-15.64N/AGap UpATPCAgape ATP0.5442 of 5 stars$1.40+2.6%N/A-65.6%$68.01M$1.29M-2.3240CORBFGlobal Cord BloodN/A$0.55-62.1%N/AN/A$66.85M$196.12M0.001,200 Related Companies and Tools Related Companies Viemed Healthcare Alternatives Oncology Institute Alternatives DocGo Alternatives Exagen Alternatives EUDA Health Alternatives Sera Prognostics Alternatives Quipt Home Medical Alternatives KindlyMD Alternatives Agape ATP Alternatives Global Cord Blood Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KDLY) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.